664
Background:
Mainstream genetic testing (GT) (hereafter referred to as “mainstreaming”), in which non-genetics clinicians provide pre-test education, obtain informed consent, facilitate testing, and disclose results, has emerged as a strategy to expand access to germline testing. However, data are limited re...
Taylor X. Urban, Saranya Lamba, Michelle C. Specht et al.· JCO Oncology Practice· 0 citations
This large collection of MBC cfDNA data is envisioned as an invaluable resource for the design and planning of future clinical trials, and cfDNA testing is now recommended in multiple advanced malignancies, including eligibility assessment for clinical trials.
I. Leshchiner, A. Medford, J. Cha et al.· Nature Communications· 0 citations
OncoRAG enables accurate clinical phenotyping from multilingual oncology notes using a locally deployable mid-size model, without model weight fine-tuning or external data sharing.
P. Salome, M. Knoll, David Walz et al.· npj Digital Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.